Variant report
Variant | nsv975416 |
---|---|
Chromosome Location | chr12:48882416-48893049 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:49)
- CpG islands (count:123)
- Chromatin interactive region (count:12)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:49 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr12:48882861-48883157 | GM12878 | blood: | n/a | chr12:48883023-48883034 |
2 | BATF | chr12:48884069-48884434 | GM12878 | blood: | n/a | n/a |
3 | BATF | chr12:48882829-48883217 | GM12878 | blood: | n/a | chr12:48883023-48883034 |
4 | BCL11A | chr12:48882852-48883267 | GM12878 | blood: | n/a | n/a |
5 | BCLAF1 | chr12:48882751-48883247 | GM12878 | blood: | n/a | n/a |
6 | BHLHE40 | chr12:48882898-48883195 | GM12878 | blood: | n/a | n/a |
7 | CEBPB | chr12:48882593-48883325 | GM12878 | blood: | n/a | n/a |
8 | CTCF | chr12:48886780-48886930 | NHLF | lung: | n/a | n/a |
9 | CUX1 | chr12:48884595-48884647 | GM12878 | blood: | n/a | n/a |
10 | E2F4 | chr12:48882935-48883203 | MCF10A-Er-Src | breast: | n/a | n/a |
11 | EBF1 | chr12:48884085-48884398 | GM12878 | blood: | n/a | n/a |
12 | EBF1 | chr12:48882812-48883124 | GM12878 | blood: | n/a | chr12:48882931-48882942 |
13 | EBF1 | chr12:48882732-48883206 | GM12878 | blood: | n/a | chr12:48882931-48882942 |
14 | EP300 | chr12:48882788-48883206 | GM12878 | blood: | n/a | n/a |
15 | EP300 | chr12:48882814-48883236 | GM12878 | blood: | n/a | n/a |
16 | FOS | chr12:48882823-48883213 | MCF10A-Er-Src | breast: | n/a | n/a |
17 | FOS | chr12:48882825-48883232 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | FOS | chr12:48882762-48883225 | MCF10A-Er-Src | breast: | n/a | n/a |
19 | FOS | chr12:48882837-48883421 | MCF10A-Er-Src | breast: | n/a | n/a |
20 | FOXM1 | chr12:48882633-48883283 | GM12878 | blood: | n/a | n/a |
21 | IRF4 | chr12:48882820-48883124 | GM12878 | blood: | n/a | n/a |
22 | IRF4 | chr12:48882807-48883262 | GM12878 | blood: | n/a | n/a |
23 | MYC | chr12:48882797-48883582 | MCF10A-Er-Src | breast: | n/a | n/a |
24 | MYC | chr12:48882824-48883500 | MCF10A-Er-Src | breast: | n/a | n/a |
25 | NFIC | chr12:48882423-48883336 | GM12878 | blood: | n/a | n/a |
26 | POLR2A | chr12:48889038-48889116 | MCF10A-Er-Src | breast: | n/a | n/a |
27 | POLR2A | chr12:48882470-48882524 | MCF10A-Er-Src | breast: | n/a | n/a |
28 | POLR2A | chr12:48882749-48883524 | MCF10A-Er-Src | breast: | n/a | n/a |
29 | POLR2A | chr12:48886005-48886242 | MCF10A-Er-Src | breast: | n/a | n/a |
30 | POLR2A | chr12:48884670-48884745 | MCF10A-Er-Src | breast: | n/a | n/a |
31 | POLR2A | chr12:48883021-48883149 | MCF10A-Er-Src | breast: | n/a | n/a |
32 | RUNX3 | chr12:48883878-48884459 | GM12878 | blood: | n/a | n/a |
33 | RUNX3 | chr12:48882700-48883303 | GM12878 | blood: | n/a | n/a |
34 | RUNX3 | chr12:48882835-48883231 | GM12878 | blood: | n/a | n/a |
35 | RUNX3 | chr12:48884027-48884396 | GM12878 | blood: | n/a | n/a |
36 | SP1 | chr12:48882811-48883134 | GM12878 | blood: | n/a | n/a |
37 | SP1 | chr12:48882789-48883194 | GM12878 | blood: | n/a | n/a |
38 | SPI1 | chr12:48885297-48885411 | K562 | blood: | n/a | n/a |
39 | SRF | chr12:48882983-48883111 | GM12878 | blood: | n/a | chr12:48883067-48883080 chr12:48883069-48883078 chr12:48883068-48883082 chr12:48883068-48883079 |
40 | SRF | chr12:48882885-48883223 | GM12878 | blood: | n/a | chr12:48883067-48883080 chr12:48883069-48883078 chr12:48883068-48883082 chr12:48883068-48883079 |
41 | SRF | chr12:48882914-48883195 | GM12878 | blood: | n/a | chr12:48883067-48883080 chr12:48883069-48883078 chr12:48883068-48883082 chr12:48883068-48883079 |
42 | STAT3 | chr12:48882822-48883227 | MCF10A-Er-Src | breast: | n/a | n/a |
43 | STAT3 | chr12:48882874-48883143 | MCF10A-Er-Src | breast: | n/a | n/a |
44 | STAT3 | chr12:48882800-48883232 | MCF10A-Er-Src | breast: | n/a | n/a |
45 | STAT3 | chr12:48882896-48883192 | GM12878 | blood: | n/a | n/a |
46 | STAT3 | chr12:48882896-48883206 | MCF10A-Er-Src | breast: | n/a | n/a |
47 | TBP | chr12:48882671-48883205 | GM12878 | blood: | n/a | n/a |
48 | WRNIP1 | chr12:48886688-48886709 | GM12878 | blood: | n/a | n/a |
49 | ZNF143 | chr12:48882852-48883158 | GM12878 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:48889853-48889903 | NHDF-neo | bronchial: | n/a |
2 | chr12:48889853-48889903 | NHDF-neo | bronchial: | n/a |
3 | chr12:48889853-48889903 | NT2-D1 | testis: | n/a |
4 | chr12:48884922-48884972 | SKMC | muscle: | n/a |
5 | chr12:48889853-48889903 | HIPEpiC | eye: | n/a |
6 | chr12:48889853-48889903 | A549 | lung: | n/a |
7 | chr12:48889853-48889903 | HRPEpiC | eye: | n/a |
8 | chr12:48884922-48884972 | HUVEC | blood vessel: | n/a |
9 | chr12:48889853-48889903 | NHBE | bronchial: | n/a |
10 | chr12:48884922-48884972 | H1-hESC | embryonic stem cell: | embryo |
11 | chr12:48884922-48884972 | PrEC | prostate: | n/a |
12 | chr12:48889853-48889903 | NH-A | brain: | n/a |
13 | chr12:48884922-48884972 | HAEpiC | amniotic membrane: | n/a |
14 | chr12:48884922-48884972 | Hepatocyte | liver: | n/a |
15 | chr12:48884922-48884972 | T-47D | breast: | n/a |
16 | chr12:48889853-48889903 | GM06990 | blood: | n/a |
17 | chr12:48889853-48889903 | HRE | kidney: | n/a |
18 | chr12:48884922-48884972 | A549 | lung: | n/a |
19 | chr12:48884922-48884972 | GM12878 | blood: | n/a |
20 | chr12:48889853-48889903 | SKMC | muscle: | n/a |
21 | chr12:48889853-48889903 | HCPEpiC | choroid plexus: | n/a |
22 | chr12:48889853-48889903 | HUVEC | blood vessel: | n/a |
23 | chr12:48889853-48889903 | MCF10A-Er-Src | breast: | n/a |
24 | chr12:48889853-48889903 | HCF | heart: | n/a |
25 | chr12:48884922-48884972 | MCF-7 | breast: | n/a |
26 | chr12:48884922-48884972 | Caco-2 | colon: | n/a |
27 | chr12:48884922-48884972 | AG09309 | skin: | n/a |
28 | chr12:48884922-48884972 | GM06990 | blood: | n/a |
29 | chr12:48884922-48884972 | U87 | brain: | n/a |
30 | chr12:48889853-48889903 | K562 | blood: | n/a |
31 | chr12:48884922-48884972 | HEEpiC | esophagus: | n/a |
32 | chr12:48889853-48889903 | GM12891 | blood: | n/a |
33 | chr12:48889853-48889903 | ECC-1 | luminal epithelium: | n/a |
34 | chr12:48884922-48884972 | AG04450 | lung: | fetal |
35 | chr12:48884922-48884972 | ovcar-3 | ovarian: | n/a |
36 | chr12:48884922-48884972 | NHDF-neo | bronchial: | n/a |
37 | chr12:48889853-48889903 | U87 | brain: | n/a |
38 | chr12:48884922-48884972 | HRCEpiC | kidney: | n/a |
39 | chr12:48884922-48884972 | Hela-S3 | cervix: | n/a |
40 | chr12:48884922-48884972 | HCT-116 | colon: | n/a |
41 | chr12:48889853-48889903 | PANC-1 | pancreas: | n/a |
42 | chr12:48884922-48884972 | SK-N-SH_RA | brain: | n/a |
43 | chr12:48889853-48889903 | ProgFib | skin: | n/a |
44 | chr12:48884922-48884972 | BE2_C | brain: | n/a |
45 | chr12:48889853-48889903 | T-47D | breast: | n/a |
46 | chr12:48889853-48889903 | BE2_C | brain: | n/a |
47 | chr12:48889853-48889903 | AG09309 | skin: | n/a |
48 | chr12:48889853-48889903 | SK-N-SH_RA | brain: | n/a |
49 | chr12:48889853-48889903 | HL-60 | blood: | n/a |
50 | chr12:48889853-48889903 | AoSMC | blood vessel: | n/a |
(count:12 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:48880500..48882865-chr12:48883478..48886344,3 | K562 | blood: | |
2 | chr12:48877425..48880282-chr12:48884726..48886278,2 | MCF-7 | breast: | |
3 | chr12:48888880..48891853-chr12:48895392..48897603,2 | MCF-7 | breast: | |
4 | chr12:48887538..48890353-chr12:48917589..48920002,2 | K562 | blood: | |
5 | chr12:48882871..48884702-chr12:48885100..48887755,2 | K562 | blood: | |
6 | chr12:48887453..48890090-chr12:48892571..48894412,2 | MCF-7 | breast: | |
7 | chr12:48880029..48882865-chr12:48884102..48887272,3 | K562 | blood: | |
8 | chr12:48887453..48890090-chr12:48892571..48894412,2 | MCF-7 | breast: | |
9 | chr12:48880500..48882865-chr12:48883478..48886344,3 | K562 | blood: | |
10 | chr12:48882871..48884702-chr12:48885100..48887755,2 | K562 | blood: | |
11 | chr12:48880029..48882865-chr12:48884102..48887272,3 | K562 | blood: | |
12 | chr12:48875260..48877080-chr12:48883909..48886028,2 | K562 | blood: |
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-OR8S1-2 | chr12:48888581-48888762 | NONHSAT028007 |
2 | lnc-OR8S1-2 | chr12:48889964-48890169 | NONHSAT028007 |
3 | lnc-OR8S1-2 | chr12:48886677-48886778 | NONHSAT028007 |
No data |
No data |
Variant related genes | Relation type |
---|---|
C12orf54 | TF binding region |
C12orf54 | CpG island |
ENSG00000197376 | chromatin interactions |
ENSG00000240443 | chromatin interactions |
ENSG00000177627 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs187356941 | chr12:48882424-48882425 | Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs533619834 | chr12:48882437-48882438 | Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs145158565 | chr12:48882440-48882441 | Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs549983112 | chr12:48882515-48882516 | Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs569846254 | chr12:48882532-48882533 | Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs535420820 | chr12:48882541-48882542 | Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs2705126 | chr12:48882562-48882563 | Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
8 | rs567966329 | chr12:48882563-48882564 | Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs533842857 | chr12:48882588-48882589 | Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs554078127 | chr12:48882595-48882596 | Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs201188992 | chr12:48882662-48882663 | Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs368968008 | chr12:48882692-48882693 | Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs371373533 | chr12:48882726-48882727 | Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs140626422 | chr12:48882727-48882728 | Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs374816095 | chr12:48882754-48882755 | Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs142410491 | chr12:48882760-48882761 | Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs375262710 | chr12:48882761-48882762 | Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs367910045 | chr12:48882762-48882763 | Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs200302287 | chr12:48882774-48882775 | Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs369170617 | chr12:48882785-48882786 | Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs144943203 | chr12:48882815-48882816 | Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs576223126 | chr12:48882831-48882832 | Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs200088977 | chr12:48882853-48882854 | Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs561672754 | chr12:48882904-48882905 | Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs376207526 | chr12:48882911-48882912 | Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs572738575 | chr12:48882921-48882922 | Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs200901187 | chr12:48882943-48882944 | Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs73298787 | chr12:48882966-48882967 | Enhancers Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs564826890 | chr12:48883000-48883001 | Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs2705127 | chr12:48883012-48883013 | Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
31 | rs2731096 | chr12:48883020-48883021 | Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
32 | rs149045798 | chr12:48883029-48883030 | Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs143004237 | chr12:48883049-48883050 | Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs548923950 | chr12:48883053-48883054 | Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs112381252 | chr12:48883110-48883111 | Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs111840037 | chr12:48883119-48883120 | Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs535065864 | chr12:48883173-48883174 | Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs190977744 | chr12:48883174-48883175 | Enhancers Weak transcription Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs200739829 | chr12:48883208-48883209 | Enhancers Active TSS Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs370397633 | chr12:48883209-48883210 | Enhancers Active TSS Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs56968979 | chr12:48883225-48883226 | Enhancers Active TSS Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs182756388 | chr12:48883287-48883288 | Enhancers Active TSS Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
43 | rs35342454 | chr12:48883301-48883302 | Enhancers Active TSS Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
44 | rs548974799 | chr12:48883302-48883303 | Enhancers Active TSS Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
45 | rs140377696 | chr12:48883308-48883309 | Enhancers Active TSS Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs2731097 | chr12:48883311-48883312 | Enhancers Active TSS Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs556347734 | chr12:48883342-48883343 | Enhancers Active TSS Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs537974979 | chr12:48883381-48883382 | Enhancers Active TSS Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
49 | rs576162553 | chr12:48883396-48883397 | Enhancers Active TSS Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
50 | rs188122959 | chr12:48883406-48883407 | Enhancers Active TSS Flanking Active TSS | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Seminomas | 18059402 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Lissencephaly | 21572526 | CNVD |
Lung cancer | 18438408 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Breast cancer | 19602461 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 18632612 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Melanoma | 18172304 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
liposarcomas | 17372913 | CNVD |
Non-small cell lung cancer | 24170126 | CNVD |
Cancer | 16751803 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Bladder cancer | 21909424 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Breast cancer | 17661082 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21785460 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:48881000-48882800 | Enhancers | NHEK | skin |
2 | chr12:48881600-48883800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr12:48881600-48884000 | Enhancers | HMEC | breast |
4 | chr12:48882200-48882600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
5 | chr12:48882400-48882600 | Flanking Active TSS | Foreskin Keratinocyte Primary Cells skin02 | Skin |
6 | chr12:48882400-48884000 | Enhancers | GM12878-XiMat | blood |
7 | chr12:48882600-48883000 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
8 | chr12:48882600-48883600 | Flanking Active TSS | Foreskin Keratinocyte Primary Cells skin03 | Skin |
9 | chr12:48882800-48883200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
10 | chr12:48882800-48883400 | Flanking Active TSS | NHEK | skin |
11 | chr12:48883000-48883200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
12 | chr12:48883200-48884000 | Active TSS | Foreskin Keratinocyte Primary Cells skin02 | Skin |
13 | chr12:48883400-48884000 | Enhancers | NHEK | skin |
14 | chr12:48883600-48883800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
15 | chr12:48883800-48885200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
16 | chr12:48884000-48884200 | Flanking Active TSS | Foreskin Keratinocyte Primary Cells skin02 | Skin |
17 | chr12:48887000-48891800 | Weak transcription | Brain Hippocampus Middle | brain |
18 | chr12:48887600-48890000 | Weak transcription | Brain Inferior Temporal Lobe | brain |
19 | chr12:48888000-48888600 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
20 | chr12:48888400-48888600 | Weak transcription | Spleen | Spleen |
21 | chr12:48888600-48888800 | ZNF genes & repeats | Spleen | Spleen |
22 | chr12:48888800-48891000 | Weak transcription | Spleen | Spleen |